Jetzt bei Plus500 CFDs auf die weltweit gefragtesten Basiswerte wie Aktien, Indizes oder Kryptowährungen entdecken!5 -W-
31.10.2024 12:24:33

Bristol-Myers Squibb Co. Q3 Profit Decreases, But Beats Estimates

(RTTNews) - Bristol-Myers Squibb Co. (BMY) announced earnings for third quarter that decreased from last year but beat the Street estimates.

The company's earnings came in at $1.211 billion, or $0.60 per share. This compares with $1.928 billion, or $0.93 per share, in last year's third quarter.

Excluding items, Bristol-Myers Squibb Co. reported adjusted earnings of $3.650 billion or $1.80 per share for the period.

Analysts on average had expected the company to earn $1.49 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 8.4% to $11.892 billion from $10.966 billion last year.

Bristol-Myers Squibb Co. earnings at a glance (GAAP) :

-Earnings (Q3): $1.211 Bln. vs. $1.928 Bln. last year. -EPS (Q3): $0.60 vs. $0.93 last year. -Revenue (Q3): $11.892 Bln vs. $10.966 Bln last year.

Analysen zu Bristol-Myers Squibb Co.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Bristol-Myers Squibb Co. 55,38 -0,88% Bristol-Myers Squibb Co.